China
一临云科技 | EClinCloud is a China-based life sciences technology company with a mission to bring effective treatment to patients through technological innovation. The company offers a seamlessly integrated platform covering scale management, language verification, research design, EDC, CTMS, eTMF, and expertise in various therapeutic fields such as oncology, neurology, cardiology, respirology, and dermatology. EClinCloud aims to become the world’s leading "patient-centered" SaaS cloud platform, partnering with pharmaceutical companies and research institutions to enhance the efficiency of research and development for new drugs and medical devices, ultimately delivering therapies to patients faster.
EClinCloud operates in the computing, health care, and SaaS industries and received a Series A investment on 01 December 2021 from Jun Capital. With its focus on leveraging technology to improve patient treatment, EClinCloud presents an intriguing opportunity for investors looking to support innovative solutions in the life sciences sector.
